Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | -2.33% | +37.25% | -68.62% |
26/04 | Top Premarket Decliners | MT |
25/04 | Top Midday Gainers | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.14M 512M |
---|---|---|---|---|---|
Net income 2024 * | -12M -1B | Net income 2025 * | -14M -1.17B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.31
x | P/E ratio 2025 * |
-0.36
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.57% |
Latest transcript on Processa Pharmaceuticals, Inc.
1 day | -2.33% | ||
1 week | +37.25% | ||
Current month | -11.21% | ||
1 month | -11.21% | ||
3 months | -24.46% | ||
6 months | -67.94% | ||
Current year | -68.62% |
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 29/11/29 |
Sian Bigora
FOU | Founder | 63 | 29/11/29 |
David Young
FOU | Founder | 71 | 29/11/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 08/23/08 |
James Neal
BRD | Director/Board Member | 68 | 16/22/16 |
Justin Yorke
CHM | Chairman | 58 | 02/17/02 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 2.1 | -2.33% | 370,889 |
26/24/26 | 2.15 | -11.52% | 1,856,628 |
25/24/25 | 2.43 | +50.00% | 77,210,296 |
24/24/24 | 1.62 | +1.25% | 39,614 |
23/24/23 | 1.6 | +4.58% | 24,735 |
Delayed Quote Nasdaq, April 30, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.62% | 6.14M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- PCSA Stock